Core Scientific, Inc/tx Form 4 insider transactions

Todd M Duchene, See remarks of Core Scientific, Inc./tx, sold 10,000 shares of common stock on October 12, 2026 for $15.12 per share.

Todd M Duchene, See remarks of Core Scientific, Inc./tx, sold 10,000 shares of common stock on October 5, 2026 for $16.31 per share.

Adam Taylor Sullivan, Chief Executive Officer and a Director of Core Scientific, Inc./tx, reported a transaction in 23,508 shares of common stock on October 1, 2026.

Todd M Duchene, See remarks of Core Scientific, Inc./tx, reported a transaction in 8,228 shares of common stock on October 1, 2026.

Todd M Duchene, See remarks of Core Scientific, Inc./tx, sold 10,000 shares of common stock on September 28, 2026 for $16.76 per share.

Todd M Duchene, See remarks of Core Scientific, Inc./tx, sold 10,000 shares of common stock on September 21, 2026 for $18.37 per share.

Eric Stanton Weiss, a Director of Core Scientific, Inc./tx, purchased 6,000 shares of common stock on September 15, 2026 for $16.33 per share.

Todd M Duchene, See remarks of Core Scientific, Inc./tx, sold 10,000 shares of common stock on September 14, 2026 for $17.14 per share.

Todd M Duchene, See remarks of Core Scientific, Inc./tx, sold 10,000 shares of common stock on September 8, 2026 for $18.67 per share.

Todd M Duchene, See remarks of Core Scientific, Inc./tx, sold 10,000 shares of common stock on August 31, 2026 for $16.23 per share.

Todd M Duchene, See remarks of Core Scientific, Inc./tx, sold 10,000 shares of common stock on August 24, 2026 for $17.45 per share.

Elizabeth Crain, a Director of Core Scientific, Inc./tx, purchased 6,000 shares of common stock on August 20, 2026 for $18.33 per share.

Eric Stanton Weiss, a Director of Core Scientific, Inc./tx, purchased 7,000 shares of common stock on August 18, 2026 for $19.19 per share.

Todd M Duchene, See remarks of Core Scientific, Inc./tx, sold 10,000 shares of common stock on August 17, 2026 for $20.10 per share.

Todd M Duchene, See remarks of Core Scientific, Inc./tx, sold 10,000 shares of common stock on August 10, 2026.

Mark Adams, a Director of Core Scientific, Inc./tx, received 27,594 shares of common stock on July 30, 2026.

Todd M Duchene, See remarks of Core Scientific, Inc./tx, sold 10,000 shares of common stock on July 27, 2026.

Todd M Duchene, See remarks of Core Scientific, Inc./tx, sold 10,000 shares of common stock on July 20, 2026 for $22.30 per share.

Adam Taylor Sullivan, Chief Executive Officer and a Director of Core Scientific, Inc./tx, reported a transaction in 15,584 shares of common stock on July 16, 2026.

Todd M Duchene, See remarks of Core Scientific, Inc./tx, reported a transaction in 4,325 shares of common stock on July 16, 2026.

Todd M Duchene, See remarks of Core Scientific, Inc./tx, sold 10,000 shares of common stock on July 13, 2026.

Core Scientific, Inc. reports that Chief Legal and Administrative Officer Todd DuChene sold 10,000 shares of common stock for $22.625 per share as part of a pre-arranged trading plan.

Core Scientific, Inc. CEO Adam Sullivan reported a transaction involving the withholding of shares to cover tax obligations upon the vesting of restricted stock units.

Core Scientific, Inc. executive Todd DuChene reported the sale of common stock under a pre-arranged trading plan, with transactions occurring on June 29 and June 30, 2026.

Core Scientific, Inc. officer Todd M. Duchene reported the sale of 10,000 shares of common stock under a pre-arranged trading plan.

Todd DuChene, Chief Legal and Administrative Officer of Core Scientific, Inc., reported the sale of 9,900 shares of common stock for $28.1875 each, executed under a pre-arranged trading plan.

Chief Legal and Administrative Officer Todd DuChene sold 10,000 shares of Core Scientific common stock via a 10b5-1 plan.

Core Scientific, Inc. reports that executive Todd DuChene sold a total of 10,000 shares of common stock under a pre-arranged trading plan.

Director Stephen M. Smith was granted 18,961 restricted stock units as part of his compensation package.

Chief Legal and Administrative Officer Todd DuChene sold 10,000 shares of Core Scientific common stock via a 10b5-1 plan.